OCDX
NASDAQ:OCDX
Ortho Clinical Diagnostics Holdings plc
- Stock
Last Close
17.47
01/01 00:00
Volume Today
789.49K
Avg: 1.01M
PE Ratio
−76.49
PFCF: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Jan '22 | ||
|---|---|---|---|---|---|---|
average inventory | 259.10M - | 266.30M 2.78% | 292.05M 9.67% | |||
average payables | 182.75M - | 172.30M 5.72% | 163.60M 5.05% | |||
average receivables | 340.25M - | 333.60M 1.95% | 287.95M 13.68% | |||
book value per share | -2.94 - | -3.67 24.60% | -4.67 27.21% | 1.74 137.33% | ||
capex per share | -0.43 - | -0.36 16.41% | -0.31 13.19% | -0.20 34.14% | ||
capex to depreciation | -0.28 - | -0.24 15.82% | -0.21 12.27% | -0.14 35.30% | ||
capex to operating cash flow | -1.39 - | -1.14 18.03% | -0.48 57.90% | -0.96 99.70% | ||
capex to revenue | -0.05 - | -0.04 16.36% | -0.04 14.19% | -0.02 34.33% | ||
cash per share | 0.25 - | 0.32 28.13% | 0.61 88.67% | 1.31 114.39% | ||
days of inventory on hand | 103.67 - | 100.47 3.09% | 112.01 11.48% | 110.72 1.15% | ||
days payables outstanding | 65.55 - | 78.51 19.77% | 58.76 25.16% | 65.62 11.68% | ||
days sales outstanding | 67.80 - | 70.61 4.14% | 65.86 6.72% | 45.96 30.22% | ||
debt to assets | 1.18 - | 1.23 4.15% | 1.30 5.77% | 0.88 32.32% | ||
debt to equity | -6.63 - | -5.42 18.34% | -4.37 19.40% | 7.19 264.81% | ||
dividend yield | ||||||
earnings yield | -0.03 - | -0.07 113.15% | -0.04 36.71% | -0.06 38.15% | -0.01 82.04% | |
enterprise value | 7.17B - | 7.11B 0.88% | 7.09B 0.32% | 6.92B 2.42% | ||
enterprise value over ebitda | 20.67 - | 18.91 8.49% | 24.30 28.49% | 27.29 12.33% | ||
ev to operating cash flow | 103.06 - | 49.72 51.75% | 153.75 209.21% | 24.13 84.30% | ||
ev to sales | 4.01 - | 3.95 1.66% | 4.01 1.68% | 3.39 15.63% | ||
free cash flow per share | -0.12 - | -0.04 63.77% | 0.34 878.89% | 0.01 97.25% | 1.22 13,073.42% | |
free cash flow yield | -0.01 - | -0.00 63.77% | 0.02 878.89% | 0.00 97.25% | 0.06 9,942.23% | |
graham net net | -17.56 - | -17.79 1.32% | -18.01 1.24% | -9.75 45.85% | ||
graham number | 8.61 - | 7.65 11.19% | 10.14 32.57% | 3.01 70.34% | ||
income quality | -0.58 - | -0.28 52.16% | -0.91 225.80% | -0.22 76.13% | -5.28 2,326.09% | |
intangibles to total assets | 0 - | 0.49 Infinity% | 0.47 3.86% | 0.47 0.99% | 0.43 8.00% | |
interest coverage | 0.16 - | 0.29 79.63% | 0.37 30.37% | 0.46 23.92% | 1.19 157.78% | |
interest debt per share | 17.46 - | 17.35 0.60% | 18.12 4.42% | 10.17 43.88% | ||
inventory turnover | 3.52 - | 3.63 3.19% | 3.26 10.30% | 3.30 1.16% | ||
invested capital | -5.57 - | -4.45 20.20% | -3.69 16.96% | 5.48 248.40% | ||
market cap | 3.57B - | 3.58B 0.37% | 3.57B 0.37% | 3.49B 2.24% | 4.98B 42.70% | |
net current asset value | -3.58B - | -3.58B 0.15% | -3.56B 0.71% | -1.94B 45.39% | ||
net debt to ebitda | 10.35 - | 9.42 8.96% | 12.34 30.99% | 7.66 37.97% | ||
net income per share | -0.52 - | -1.12 113.15% | -0.71 36.71% | -0.98 38.15% | -0.23 76.44% | |
operating cash flow per share | 0.31 - | 0.31 1.98% | 0.65 106.21% | 0.21 67.02% | 1.22 471.51% | |
payables turnover | 5.57 - | 4.65 16.51% | 6.21 33.62% | 5.56 10.46% | ||
receivables turnover | 5.38 - | 5.17 3.98% | 5.54 7.21% | 7.94 43.32% | ||
research and ddevelopement to revenue | 0.05 - | 0.06 2.07% | 0.05 1.49% | 0.06 17.51% | 0.06 3.35% | |
return on tangible assets | -0.13 - | -0.08 37.56% | -0.12 41.24% | -0.03 75.80% | ||
revenue per share | 8.04 - | 8.04 0.05% | 8.13 1.16% | 8.15 0.29% | 8.67 6.33% | |
roe | 0.38 - | 0.19 49.20% | 0.21 8.60% | -0.13 163.10% | ||
roic | 0.02 - | 0.02 2.41% | 0.03 21.55% | 0.14 410.04% | ||
sales general and administrative to revenue | ||||||
shareholders equity per share | -2.94 - | -3.67 24.60% | -4.67 27.21% | 1.74 137.33% | ||
stock based compensation to revenue | 0.00 - | 0.00 33.67% | 0.01 212.77% | 0.00 52.84% | ||
tangible asset value | -2.47B - | -2.51B 1.67% | -2.61B 3.70% | -1.04B 60.03% | ||
tangible book value per share | -11.12 - | -11.35 2.05% | -12.04 6.08% | -4.42 63.25% | ||
working capital | 188.80M - | 138.70M 26.54% | 230.80M 66.40% | 433.20M 87.69% |
All numbers in USD (except ratios and percentages)